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Neuropeptides are involved in numerous brain activities being responsible for a 
wide spectrum of higher mental functions. The purpose of this concise, structural and 
qualitative investigation was to map the possible immunoreactivity of the novel 
neuropeptide spexin (SPX) within the human magnocellular hypothalamus. SPX is a 
newly identified peptide, a natural ligand for the galanin receptors (GALR) 2/3, with no 
molecular structure similarities to currently known regulatory factors. SPX seems to 
have multiple physiological functions, with an involvement in reproduction and food-
intake regulation recently revealed in animal studies. For the first time we describe 
SPX expressing neurons in the supraoptic (SON) and paraventricular (PVN) nuclei of 
the human hypothalamus using immunohistochemical and fluorescent methods, key 
regions involved in the mechanisms of osmotic homeostasis, energy expenditure, 
consummatory behaviour, reproductive processes, social recognition and stress 
responses. The vast majority of neurons located in both examined neurosecretory 
nuclei show abundant SPX expression and this may indirectly implicate a potential 















The hypothalamus is a unique brain structure that plays a fundamental role in 
the origin and integration of central autonomous functions. This includes precise 
regulation of food intake, osmotic homeostasis, circadian rhythm, reproductive 
processes, thermoregulation, cardiovascular physiology and even aspects of affective 
activities. The potential role of hypothalamic related pathways in the origin of several 
neuropsychiatric dysfunctions is also widely postulated.  
Spexin (SPX) is a newly discovered multifunctional neuropeptide acting at both 
central and peripheral levels. SPX was identified in 2007 by Mirabeau and colleagues 
(2007) as a transcript of the Ch12orf39 gene. In the rat brain, SPX-expressing neurons 
have been detected with the highest expression being in the hypothalamic 
magnocellular nuclei (Porzionato et al. 2010).  The chemical structure of SPX is 
distinctly conserved among species, the rat molecule differs from the human form by 
only one C-terminal amino acid (Porzionato et al. 2010). SPX is an alternative 
endogenous ligand for the GALR2/3 receptors, with even higher affinity toward GALR3 
than galanin itself (Kim et al. 2014).  SPX has recently been linked to multiple 
physiological functions such as reproduction, food-intake regulation (Ma et al. 2018, 
Wong et al. 2013), cardiovascular/renal function and nociception (Toll et al. 2012, 
Porzionato et al. 2012). Due to potent anorexigenic properties of SPX, it has been 
suggested that a potential excess in hypothalamic SPX signaling may be involved in 
the pathogenesis of anorexia nervosa (Pałasz et al. 2018). A recent study therefore 
suggests a possible application of SPX for obesity therapy (Walewski et al. 
2014).rSupporting this, glucose-triggered insulin secretion may increase SPX gene 
expression in the goldfish brain (Ma et al. 2017). A role of SPX as a potential biomarker 
of glucose metabolism in humans has been also suggested (Hodges et al. 2017).  
Despite the accumulating animal studies on SPX biology, its distribution and 
physiology are so far lacking within the human brain. To date, there is no information 
available about spexin chemoarchitecture in the human hypothalamus. In the present 
study we aim to provide a structural investigation of the human hypothalamus to reveal 
the first outline for the neurochemical map of SPX expression within the neurosecretory 
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magnocellular nuclei, allowing a potential deeper mechanistic understanding of SPX 
biology to aid future therapeutic study. 
2. Materials and Methods 
 
2.1. Immunohistochemistry 
Human brain tissue specimens with no neuropathological findings were 
obtained from the Conscious Body Donation Program conducted by the Department of 
Anatomy at the Medical University of Silesia in Katowice. Brains were post mortem 
perfusion-fixed with 4% paraformaldehyde buffered solution (pH 7.2-7.4) and then 
immersion-fixed over a period of at least three months. The rostral hypothalamus was 
precisely excised from 2 diencephalic slices (n=2) according to the referenced human 
brain atlases (Mai et al. 2015, Cho 2014) as visualized in Figure 1. Samples were 
dehydrated, embedded in paraffin wax and finally sectioned by microtome (Leica 
Microsystems, Germany) at 10 μm thick serial slices. The inferior hypothalamic 
boundary was identified in the coronal plane by the optic chiasm and superior boundary 
was delineated by the anterior commissure. Third ventricle and edge of ventral 
pallidum (parallel to diagonal band of Broca) formed lateral and medial borderlines 
respectively. The sections were deparaffinized with xylene and rehydrated to 50% 
ethanol via graduated alcohol solutions.   
After rehydration and subsequent antigen retrieval with citrate buffer (pH 4.0) 
solution (Vector Laboratories) at 60 0C sections were rinsed three times for 5 min in 
0.05 M TBS-saline (pH 7.6) and placed in PBS with 0.1% Triton X-100 (Sigma). They 
were blocked with 10%, goat serum and incubated overnight at 40C with rabbit anti-rat 
spexin polyclonal antiserum (1:2000, Phoenix Pharmaceuticals). Additionally, for a 
complementary internal reference some specimens were placed in goat monoclonal 
antibody against rat nesfatin-1 (1:1000, Enzo Life Sciences). All sections were treated 
with TrueBlack® (Biotium, Hayward, CA, USA) to remove unwanted lipofuscin 
autofluorescence. Following incubation with primary antibodies brain sections were 
kept in complete darkness with secondary antibodies labeled with FITC or TRITC 
(1:200, Abcam) for SPX, nesfatin-1 respectively, and mounted on slides with DAPI-
containing medium. Alternatively, rabbit anti-rat spexin polyclonal antibody (1:500 
Phoenix Pharmaceuticals) was followed by biotinylated goat anti-rabbit secondary 
antibody and then an avidin-biotin-horseradish peroxidase complex (Vectastain ABC 
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kit, Vector Labs) and visualised with3,3’-diaminobenzidine (DAB). Because rodent and 
human SPX molecules differ in only one amino acid we checked the SPX antibody 
specificity with an absorption test with human SPX (Phoenix Pharmaceuticals) as 
previously reported (Gu et al. 2015). The crucial point of this test was a preincubation 
of the SPX (pure antigen) with the antibody before the essential IHC reaction. 
Moreover, this antiserum has also been verified using series of human positive controls 
(stomach and intestine tissues). All sections were mounted on glass slides, dehydrated 
and coverslipped. For basic neurostructural evaluation, representative sections were 
stained via Nissl method in 1% Cresyl violet for 60 mins. After rinsing and differentiation 
by acetic acid and mounting with DPX, sections were cover slipped. All images were 
captured with Nikon Coolpix fluorescent optic systems and processed using Image 
ProPlus software (Media Cybernetics, USA). The SON/PVN cyto- and 
chemoarchitecture was analyzed and immunopositive cells were counted using 
ImageJ 1.43u software. The anatomical coordinates and structure of the hypothalamus 
were defined after Borgers et al. (2013).  The number of SPX-positive cells was 
counted in SON and PVN nuclei to obtain the density of these cells per standardized 
area (0.16 mm2, frame 400 x 400m). Data are presented as a mean ± standard error 





Upon examining the SON, a distinct majority of large-sized, oval or round neurons 
showed intense SPX immunostaining and fluorescence (Fig.1 and 2). Other, smaller 
cells that displayed a wide spectrum of shapes (fusiform, droplet-shaped or multipolar 
perikarya) exhibited medium SPX immunoreactivity (Fig.2). The highest density of 
large, SPX-positive cells were observed in the posterior SON sections; mean number 
of SPX-positive cells in SON ranged from 10 ± 2% in the rostral to 37 ± 2% in the 
caudal part of the nucleus (Fig.2). In the SON a bigger proportion of multiform 
neuropeptide immunopositive cells was found which, depending on section plane, 
presented a more anterior orientation. Of note, the medium-sized, oval-shaped 
perikarya of the entire SON exhibit a distinct but not intense SPX immunoreactivity 
(Fig.2; B1-B3). Most SPX-expressing neurons in the PVN had large elongated, 
irregular-shaped, multipolar or triangular perikarya but smaller round cells were also 
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found (Fig. 2; B,D,E). The intensity of fluorescence was slightly lower when compared 
to the SON. Mean number of SPX-positive cells in the PVN ranged from 17± 2% in the 
rostral, to 29 ± 2% in the caudal part of the nucleus. (Fig.2). Looking at the intracellular 
aspect of SPX immunohistochemistry regular reticular and perinuclear DAB staining 
indicates a labelling of the endoplasmic reticulum and Golgi apparatus,especially 
within the large SON neurons (Fig 2.). Within some of these cells, aslightly thickened 
nuclear membrane was distinctly DAB stained. The results of the fluorescence staining 
was also evenly distributed in the SON neurons, while some SPX immunopositive 
granules and varicosities were also identified in several long axons located between 
the SON neurosecretory cells. Overall immunoreactivity was less abundant in the PVN 
neurons, however those with oval morphology had exposed dense reticular staining of 
both the perinuclear and peripheral cell region; while axonal positivity in the PVN was 




We have demonstrated for the first time SPX immunoreactive neurons in the 
human magnocellular hypothalamus, suggesting that this novel neuropeptide may be 
involved in autonomic functions mediated by this brain region. The chemoarchitecture 
of SPX neurons in the SON and PVN is similar to the distribution of nesfatin-1 which 
previously was shown to colocalize with oxytocin and vasopressin (Psilopanagioti et 
al. 2019), CRH (Bao and Swaab 2010), 26RFa (Bruzzone et al. 2006), CART (Elias et 
al. 2001) and galanin (Gai et al. 1990). SPX immunoreactivity was the most abundant 
in the large round, fusiform and multipolar perikarya that represent type II and III human 
SON neurons, as defined by the Golgi method-based morphological classification (Al-
Hussain and Al-Jomard 1996). Most positive cells were bipolar with short and simple 
branching dendritic processes (Armstrong 1995). Of note, the size of SON/PVN 
neurons may enlarge with normal aging (Vogel et al. 1990). The majority of smaller, 
elongated and ovoidal type I and IV somata were characterized by lower intensity of 
SPX-immunoexpression. The most prominent SPX-expression was observed in the 
vasopressinergic magnocellular part of PVN occupying ventral area of the nucleus. A 
dorsally located population of large spindle-shaped perikarya was also SPX-positive. 
Previous studies revealed that this group of human PVN neurons have a distinct tyrosin 
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hydroxylase expression and release oxytocin (Qin et al. 2018, Koutcherov et al. 2000). 
The present study revealed that the SPX expression in the human SON and PVN is 
homologous to the neuropeptide chemoarchitecture in the rat magnocellular nuclei 
(Porzionato et al. 2010), adding weight to the translational relevance of previous rat 
studies. Given a significant co-distribution of SPX, vasopressin and oxytocin in cells 
within the hypothalamus, this may potentially indicate functional interactions between 
these neuropeptides, but this should be cautiously taken into consideration. SPX may 
therefore potentially be involved in the central control of osmotic homeostasis and 
reproductive processes in humans. Since SON and PVN neurons receive both 
excitatory and inhibitory afferents from other hypothalamic, limbic and brainstem 
structures, (Iovino et al. 2016, Leng et al. 1999) it should not be excluded that SPX 
synthesis may be regulated by these brain centres.   
At present, there is no clear consensus on the contribution of SPX to human 
hypothalamus function, moreover it is not yet known how SPX and its receptors are 
regulated in this central autonomic structure, crucial for homeostatic balance. The 
pattern of SPX distribution in the human hypothalamus mirrors the rat (Porzionato et 
al. 2010) and to some extent even goldfish (Wong et al. 2013), with the most intense 
immunoreactivity in SON and slightly lower in PVN. One can therefore suggest that 
SPX role in the human hypothalamic nuclei may be potentially analogous to that 
revealed in the animal brain. A presence of SPX in the magnocellular neurosecretory 
centres suggests that this regulatory factor may be secreted into the blood via the 
hypophyseal circulation and can act as a multifunctional neurohormone. 
Animal studies, have shown that SPX reduces food intake and body weight and 
may induce satiety via blockage of neuropeptide Y/orexin signalling (Ma et al. 2015) 
and by suppressing AgRP (Zheng et al. 2017). Thus, SPX is currently considered as a 
potent central, and probably peripheral, novel anorexigenic neuropeptide. SPX can 
also increase locomotion and lipid oxidation and improve glucose tolerance (Walewski 
et al. 2014). Endogenous SPX acting as a ligand of GalR2 and GalR3 receptors could 
also play a role in the pathophysiology of depression and anxiety (Swanson et al. 
2005). 
 GalR2 shows a high distribution in several hypothalamic nuclei (Bartfai et al. 
1993) including SON and PVN (Gundlach and Burazin 1998), where they can 
potentially be stimulated by SPX. Hence, a variety of biological effects exerted by 
central galanin signalling such as regulation of energy homeostasis (feeding, 
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metabolism and body weight control), cognitive functions, learning and memory 
(Bartfai et al. 1992,1993) may be SPX-related. At the level of hypothalamic circuits, 
galanin stimulates feeding behavior (Leibowitz et al. 1992), growth hormone (Bauer et 
al. 1986, Murakami et al. 1987) and prolactin (Koshiyama et al. 1990) exocytosis, but 
inhibits corticosterone release (Tempel et al. 1990). The central anti-nociceptive 
actions of galanin (Xu et al. 2010) are exerted via GalR1 (Fu et al. 2011) and GalR2 
activation (Zhang et al. 2017) in the hypothalamic nuclei (Amorim et al. 2015, Gu et al. 
2007), nucleus accumbens (Duan et al. 2015), central nucleus of amygdala (Jin et al. 
2010) or in the spinal cord (Xu et al. 2012).  This important effect of GalR2 activation 
may be also related to local SPX release within the hypothalamus, that may modulate 
nociceptive signalling mechanisms (Toll et all. 2012).  
 The latest study reveals that SPX may participate in serotonin-dependent 
regulation of anxiety behaviour in zebrafish (Jeong et al. 2019). It was recently reported 
that long-term treatment with selective serotonin reuptake inhibitors escitalopram 
decreased the SPX expression in the rat hypothalamus but increased levels in the 
hippocampus and striatum (Pałasz et al. 2016). Studies on primary cultures of mouse 
immortalized hypothalamic neurons showed that SPX mRNA expression is acutely 
modulated by palmitate and nitric oxide. Stress-related injury of endoplasmic reticulum 
as well as C/EBP-b signalling also affect both SPX and GALR2/3 gene expression in 
these cells (Tran et al. 2019). SPX is also involved in the hypothalamus-related control 
of cardiovascular physiology and reproductive processes (Porzionato et al. 2012, Liu 
et al. 2019, Kumar et al. 2018, Lv et al. 2018). Of note, a recent study reported 
increased serum SPX concentrations in pregnant women with gestational diabetes 
mellitus (Akbas et al. 2019). Nothing is known about the factors regulating SPX 
expression in either animal or human brains, therefore a large spectrum of speculative 
possibilities, including the aforementioned should be taken into consideration. 
Given the small number of brain samples, it is worth considering expanding the 
study to complement our initial report. Nevertheless, given the scarcity of human brain 
tissue, we believe that this initial report will offer a much-needed initial neurochemical 
map of SPX expression. Although confirmation of SPX neurochemistry requires 
numerous further neurostructural and molecular studies, even at the present stage of 
knowledge this regulatory peptide can be considered as an interesting and potentially 
important regulatory factor in the human hypothalamus. 
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At present, a role of SPX in human neurophysiology still remains an area of 
speculation, but undoubtedly further studies on this regulatory factor, e.g. on its 
coexpression with other important  neuropeptides  both classical (vasopressin, 
oxytocin, CRF, NPY, somatostatin) and novel (nesfatin-1, phoenixin, alarin) definitely 
merits attention. Moreover, the 3-D visualization of the aforementioned neuropeptide 
distribution in the whole human hypothalamus, as well as study of potential interactions 
between these factors is of paramount importance. To conclude, our investigation 
presents the novel identification of SPX expressing neurons in the human 
hypothalamus and their assemblies show similar patterns of distribution in SON and 
PVN. The study demonstrates for the first time a presence of SPX in the human brain 
which could implicate a potential contribution of this neuropeptide to numerous central 





To conclude, our investigation presents the novel identification of SPX expressing 
neurons in the human hypothalamus and their assemblies show similar patterns of 
distribution in SON and PVN. The study demonstrates for the first time a presence of 
SPX in the human brain which could implicate a potential contribution of this 
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Fig.1. Macroscopic overview of the serial brain sections containing examined 
hypothalamic regions, Nissl staining (top panel). Scale bar: 5mm. Supraoptic, SON 
and paraventricular, PVN nuclei (yellow); anterior commissure, ac; lateral ventricle, lv; 
hypothalamus, hyp; third ventricle, 3v. Microstructure of SON; fig. A, A1 and PVN fig. 
F, F1. Nissl staining. Scale bars: 200m (A,F) and 100 m (A1,F1). Spexin (SPX) 
expression in the magnocellular hypothalamus. Immunohistochemistry (DAB), 
supraoptic nucleus; fig. B-E, paraventricular nucleus; fig. G-J. Scale bars:  200 m. 
Fluorescence (FITC), SON; fig. B1-E1, PVN; fig. G1-J1. Scale bars: 100 m. 
 
Fig.2. Mean number of SPX immunopositive cells per standarized frame (0.16 mm2) 
counted from rostral to caudal magnocellular SON and PVN (upper panel). A selection 
of neurons under higher magnification. Immunohistochemical DAB reaction for SPX in 
SON (fig. A,D), fluorescence for SPX (FITC, fig. B,E) and nesfatin-1 (TRITC; fig. C,F) 










• SPX-expressing neurons are present in the human supraoptic and paraventricular 
nuclei 
• SPX immunoreactivity is slightly higher in the supraoptic than in the paraventricular 
nucleus 
• The highest density of SPX-positive neurons is observed in the posterior part of  
supraoptic nucleus 
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